DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹17,717 Cr |
Mar2024 | ₹15,937 Cr |
Mar2023 | ₹14,863 Cr |
Mar2022 | ₹14,619 Cr |
Mar2021 | ₹11,387 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹17,717 Cr | 11.17 | |
Mar2024 | ₹15,937 Cr | 7.23 | |
Mar2023 | ₹14,863 Cr | 1.67 | |
Mar2022 | ₹14,619 Cr | 28.39 | |
Mar2021 | ₹11,387 Cr | - |
Compare Total Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,650.1 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics | |
MANKIND PHARMA | ₹105,776.0 Cr | -0.2% | -1.7% | 6.8% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | NA |
-1.6% |
12.1% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses